Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL6142875 | 0.92 | MEN1 (0.34) | CA2 | |
| SCHEMBL1076991 | 0.91 | PIK3CD (0.36) | PIK3CD | |
| SCHEMBL892398 | 0.87 | CA2 (0.32) | CA2 | |
| SCHEMBL15503611 | 0.85 | LMNA (0.32) | CA2 | |
| SCHEMBL23647292 | 0.80 | CA2 (0.44) | CA2 | |
| SCHEMBL5668460 | 0.80 | CA2 (0.44) | CA2 | |
| SCHEMBL11219700 | 0.80 | CA2 (0.44) | CA2 | |
| SCHEMBL125676 | 0.80 | CA2 (0.44) | CA2 | |
| SCHEMBL10835191 | 0.80 | CA2 (0.44) | CA2 | |
| SCHEMBL16546847 | 0.80 | CA2 (0.44) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353038-B2 | Methods for preparing fluorinated vinyl ethers | BAXTER INTERNATIONAL, INC. (US) | 2016-05-31 | — | — | US | disclosed |
| EP-2370419-A1 | MALTOL ETHER PROCESSES AND INTERMEDIATES | Shionogi&Co., Ltd. (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20100267995-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INTERNATIONAL INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010067176-A1 | MALTOL ETHER PROCESSES AND INTERMEDIATES | SHIONOGI & CO., LTD. (JP) | 2010-06-17 | — | — | WO | disclosed |
| US-7687635-B2 | Metal complexes useful in metathesis and other reactions | TELENE S.A.S. (FR) | 2010-03-30 | — | — | US | disclosed |
| EP-1743899-B1 | Metal complexes for use in metathesis, atom transfer radical reactions, addition polymerisation and vinylation reactions, methods and intermediates for making them | TELENE SAS (FR) | 2009-04-22 | — | — | EP | disclosed |
| EP-1206937-B1 | NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR THE TREATMENT OF ATOPIC DERMATITIS | SHOEI CO LTD (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070185343-A1 | Metal complexes for use in olefin metathesis and atom group transfer reactions | UNIVERSITEIT GENT (BE) | 2007-08-09 | — | — | US | disclosed |
| EP-1414867-B1 | POLYMERS AND THEIR SYNTHESIS | UNILEVER PLC (GB) | 2007-03-14 | — | — | EP | disclosed |
| EP-1743899-A1 | Metal complexes for use in metathesis, atom transfer radical reactions, addition polymerisation and vinylation reactions, methods and intermediates for making them | Universiteit Gent (BE) | 2007-01-17 | — | — | EP | disclosed |
| US-6448247-B1 | TACHYKININ RECEPTOR ANTAGONIST; ESPECIALLY TO THE RECEPTORS FOR SUBSTANCE P (WHICH RECEPTORS ARE GENERALLY REFERRED TO AS ?NEUROKININ 1 RECEPTORS?) | SANKYO COMPANY, LIMITED (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-1206937-A1 | NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR DERMATOSIS | SHOEI CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-0776893-B1 | Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 | SANKYO CO (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-6159967-A | Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use | SANKYO COMPANY, LIMITED (JP) | 2000-12-12 | — | — | US | disclosed |
| US-5763548-A | ADDITION POLYMERIZATION USING TRANSITION METAL CATALYSTS | CARNEGIE-MELLON UNIVERSITY (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0776893-A1 | Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 | SANKYO COMPANY LIMITED (JP) | 1997-06-04 | — | — | EP | disclosed |
| EP-0183848-A1 | POLYAZAHETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-06-11 | — | — | EP | disclosed |
| EP-0024965-B1 | FLUORINATED METHYL BETA-ALANINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-04-27 | — | — | EP | disclosed |
| US-4375477-A | ENZYME INHIBITORS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-03-01 | — | — | US | disclosed |
| EP-0024965-A1 | Fluorinated methyl beta-alanine derivatives, their preparation and pharmaceutical compositions containing them | MERRELL TORAUDE ET COMPAGNIE (FR) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185343-A1 | Metal complexes for use in olefin metathesis and atom group transfer reactions | ME1, ME3, COASY | CA2 763/4885PIK3CD 4179/4885 |
| US-20100267995-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | VAV1, CYP4F2, CYP2F1 | CA2 691/4885PIK3CD 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.